Browse Drug Recalls
1,309 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 1,309 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 1,309 FDA drug recalls in 2014.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| May 12, 2014 | Papaverine HCl 30 mg, Phentolamine Mesylate 1 mg, Alprostadil 10 mcg, a) 5 mL... | Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled inje... | Class II | John W Hollis Inc |
| May 12, 2014 | LIPOTROPIC GOLD, Each mL contains: Levocarnitine 5 mg, Thiamine 50 mg, Ribofl... | Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled inje... | Class II | John W Hollis Inc |
| May 12, 2014 | Papaverine HCl 30 mg, Phentolamine Mesylate 0.5 mg, Alprostadil 10 mcg, a) 5 ... | Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled inje... | Class II | John W Hollis Inc |
| May 12, 2014 | Polidocanol 5% Solution for Injection, each mL contains Polidocanol (Laureth ... | Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled inje... | Class II | John W Hollis Inc |
| May 12, 2014 | B-Complex/Adenosine Inj sol, Adenosine-5-Monophosphate 0.03g, Choline Chlorid... | Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled inje... | Class II | John W Hollis Inc |
| May 12, 2014 | METHYLCOBALAMIN FOR INTRAMUSCULAR OR SUBCUTANEOUS USE ONLY, Methylcobalamin 1... | Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled inje... | Class II | John W Hollis Inc |
| May 12, 2014 | Testosterone Cypionate for Injection, each mL contains Testosterone Cypionate... | Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled inje... | Class II | John W Hollis Inc |
| May 12, 2014 | Papaverine HCl 30 mg, Phentolamine Mesylate 1 mg, a) 5 mL and b) 10 mL, JOHN ... | Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled inje... | Class II | John W Hollis Inc |
| May 12, 2014 | 0.9 % Sodium Chloride Injection, USP, 1000 mL in VIAFLEX Plastic Container, B... | Presence of Particulate Matter; blue polyisoprene shavings found inside the bag port tubes | Class I | Baxter Healthcare Corp. |
| May 12, 2014 | MIC PLUS B12, Adenosine, L-Carnitine, Contains: Methionine 15mg, Choline 100... | Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled inje... | Class II | John W Hollis Inc |
| May 12, 2014 | CYANOCOBALAMIN FOR INTRAMUSCULAR OR SUBCUTANEOUS USE ONLY, Each mL contains: ... | Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled inje... | Class II | John W Hollis Inc |
| May 8, 2014 | PROMETHAZINE HYDROCHLORIDE Tablets, USP, 25 mg, 100 Tablet Bottles, Rx Only. ... | Presence of Foreign Tablets: Presence of atenolol 25 mg tablet mixed into promethazine 25 mg tabl... | Class II | Zydus Pharmaceuticals USA Inc |
| May 5, 2014 | AFRICAN BLACK ANT, 2800 mg, 6 capsules per box, produced by: Qinghan Hongwei ... | Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain und... | Class I | Eugene Oregon, Inc. |
| May 5, 2014 | Hemo-Stat Solution, Aluminum chloride 25%, in 37.2 g glass bottles, distribut... | Marketed without an Approved NDA/ANDA; product is being manufactured and distributed without a ND... | Class II | Axcentria Pharmaceuticals, LLC |
| May 5, 2014 | MOJO RISEN, 650 mg, 2 capsule per pouch, Distributed by: Mojo Risen, LLC, Spr... | Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain und... | Class I | Eugene Oregon, Inc. |
| May 5, 2014 | Black Ant, 2800 mg, four capsules per box, Manufacturer Qinghai Baojiantang P... | Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain und... | Class I | Eugene Oregon, Inc. |
| May 2, 2014 | Fosphenytoin Sodium Injection, USP, 100 mg PE/2 mL (50 mg PE/mL) (PE= phenyto... | Presence of Particular Matter: Potential glass delamination and consistent with glass particulate... | Class II | Fresenius Kabi USA, LLC |
| May 2, 2014 | Fosphenytoin Sodium Injection, USP, 500 mg PE/10 mL (50 mg PE/mL), (PE= pheny... | Presence of Particular Matter: Potential glass delamination and consistent with glass particulate... | Class II | Fresenius Kabi USA, LLC |
| May 1, 2014 | Calcitriol Oral Solution 1 mcg/mL, 15mL bottle, Rx only, Roxane Laboratories,... | Failed Impurity/Degradation Specification; out of specification for trans-calcitriol degradant at... | Class II | Boehringer Ingelheim Roxane Inc |
| May 1, 2014 | Dextroamphetamine Sulfate Tablets, USP, 10 mg, 100-count bottles, Rx only, Ba... | Failed Impurities/Degradation Specifications: this product is being recalled due to an out of spe... | Class II | Teva Pharmaceuticals USA |
| Apr 30, 2014 | Lite Fit USA, For Men & Women, Extreme Fat Burner, Suppresses Appetite, Boost... | Marketed Without an Approved NDA/ANDA: Bacai, Inc. DBA Ky Duyen House is voluntarily recalling Li... | Class I | Bacai Inc. Dba Ky Duyen House |
| Apr 29, 2014 | Red Yeast Rice High Potency Dietary Supplement, 600 mg, packaged in a) 120-co... | Marketed Without An Approved NDA/ANDA: Product is being recalled due to excessive levels of lovas... | Class II | Independent Nutrition Center, Inc. |
| Apr 29, 2014 | Tatiomax (reduced glutathione/hydrolyzed collagen) powder for injection vials... | Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling includes d... | Class II | Flawless Beauty LLC |
| Apr 29, 2014 | Sterile Water for Injection, 5 mL ampoules, packaged in 50-count ampoules per... | Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling indicates ... | Class II | Flawless Beauty LLC |
| Apr 29, 2014 | Relumins Advanced Glutathione (lyophilized glutathione/vitamin C) injectable ... | Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling indicates ... | Class II | Flawless Beauty LLC |
| Apr 29, 2014 | Laroscorbine Platinium (vitamin C/collagen) injectable I.V. solution, 1 gm/0.... | Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling includes d... | Class II | Flawless Beauty LLC |
| Apr 29, 2014 | Saluta (reduced glutathione) Powder for Injection, 600 mg/vial, packaged in 1... | Marketed Without An Approved NDA/ANDA: Parenteral product is labeled for use as an antidote. | Class II | Flawless Beauty LLC |
| Apr 29, 2014 | Vitamin C (ascorbic acid) Injection, USP, 500 mg per 2 mL, 50 x 2 mL ampoules... | Marketed Without An Approved NDA/ANDA: Parenteral product is sold over the counter whose labeling... | Class II | Flawless Beauty LLC |
| Apr 28, 2014 | TEV-TROPIN [somatropin (rDNA origin) for injection] 5 mg (15 IU) 1-count bott... | Chemical Contamination: TEV-TROPIN [somatropin (rDNA origin) for injection] may contain silicone ... | Class II | Ferring Pharmaceuticals Inc |
| Apr 25, 2014 | PediaCare brand NIGHTTIME MULTI-SYMPTOM Cold, (diphenhydramine HCl 6.25 mg an... | Presence of Precipitate; small amounts of diphenhydramine precipitated out of solution | Class III | Prestige Brands Holdings |
| Apr 25, 2014 | PediaCare brand DAY & NIGHT Value Pack DAYTIME MULTI-SYMPTOM Cold (dextrometh... | Presence of Precipitate; small amounts of diphenhydramine precipitated out of solution | Class III | Prestige Brands Holdings |
| Apr 24, 2014 | Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-c... | Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets. | Class II | Actavis Laboratories, FL, Inc. |
| Apr 24, 2014 | Famotidine Injection 20 mg, Rx Only, GALAXY Single Dose Container, Code 2G342... | Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting ... | Class II | Baxter Healthcare Corp. |
| Apr 24, 2014 | Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 50 mg/0.2 mg, 60-c... | Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets. | Class II | Actavis Laboratories, FL, Inc. |
| Apr 23, 2014 | QVAR¿ (beclomethasone dipropionate HFA), 80mcg Inhalation Aerosol, 50 metered... | Defective Delivery System; defective valve | Class II | Teva Pharmaceuticals USA |
| Apr 22, 2014 | Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 4279... | Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are ... | Class II | SigmaPharm Laboratories LLC |
| Apr 21, 2014 | Marcaine (bupivacaine HCl) injection, USP, 0.25%, Preservative-Free, 10 mL (2... | Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible ... | Class I | Hospira Inc. |
| Apr 21, 2014 | Glycopyrrolate 0.2 mg/ml, 5 mL pre-filled syringe, Rx Only. Pharmakon Pharma... | Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol. | Class II | Pharmakon Pharmaceuticals |
| Apr 21, 2014 | Midazolam HCl 2 mg/ml in 0.9% Sodium Chloride in 30 mL PVC Vial, Rx Only. Ph... | Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol. | Class I | Pharmakon Pharmaceuticals |
| Apr 21, 2014 | Midazolam HCl 1 mg/ml in 0.9% Sodium Chloride in 50 mL and 100 mL IV bag, Rx ... | Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol. | Class I | Pharmakon Pharmaceuticals |
| Apr 21, 2014 | Atropine Sulfate 0.4 mg/ml Injection, USP, Total Dosage 0.8 mg per 2 mL, 3 mL... | Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol. | Class I | Pharmakon Pharmaceuticals |
| Apr 21, 2014 | 0.9% Sodium Chloride Irrigation, USP, 1000 mL,Not for Injection, Manufacture... | Presence of Particulate Matter: Nylon fibers found in a bottle of 0.9% sodium chloride for irriga... | Class II | Baxter Healthcare Corp. |
| Apr 18, 2014 | Olanzapine Orally Disintegrating Tablets 5 mg, 30-count Bottle, Rx only, Manu... | Subpotent Drug: Out of specification (OOS) results at the 9 month temperature point. | Class III | Apotex Corp. |
| Apr 18, 2014 | 1% LIDOCAINE HCl Injection, USP, Preservative-Free, 10 mg/mL, 30 mL Single-do... | Presence of Particulate Matter: Confirmed customer complaint that orange and black particulates, ... | Class I | Hospira Inc. |
| Apr 17, 2014 | CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufact... | Presence of Particulate Matter: Customer complaint stating that one vial contained a glass shard. | Class I | Cubist Pharmaceuticals, Inc. |
| Apr 17, 2014 | Wockhardt Metoprolol Succinate, Extended-Release Tablets USP, 50 mg, a)100-... | Failed Dissolution Specifications: Product was out of specification (OOS) at the 12 month long te... | Class III | Wockhardt Usa Inc. |
| Apr 17, 2014 | Triveen - PRx RNF Capsules, 30-count bottles, Rx only; Manufactured for: Trig... | Labeling: Not Elsewhere Classified: Label indicates that the product contains Vitamin B12 (12 mic... | Class III | Trigen Laboratories, Inc. |
| Apr 16, 2014 | Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx ... | Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended... | Class II | Pfizer Us Pharmaceutical Group |
| Apr 15, 2014 | Children's Triacting Night Time Cold & Cough with PE (diphenhydramine hcl an... | Presence of Precipitate: Small amounts of diphenydramine and mannitol precipitated out of solution. | Class III | P&L Developments, LLC |
| Apr 15, 2014 | Super ARTHGOLD 500mg, 120 Capsule Bottle, Dietary Supplement. Manufactured f... | Marketed Without an Approved NDA/ANDA; Product contains undeclared indomethacin, diclofenac, and ... | Class I | Sung Soo Kim |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.